We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6857:TSEAdvantest Corp. Analysis

Data as of 2026-03-09 - not real-time

¥22,875.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Advantest is trading below its 20‑day and 50‑day moving averages while staying above the 200‑day average, a pattern that suggests short‑term weakness within a longer‑term uptrend. The RSI sits in the low‑mid 30s, hinting at limited upside momentum, and the MACD histogram is negative, reinforcing a bearish technical signal. Fundamentally, the company delivers robust performance – revenue is expanding at roughly 25% year‑over‑year, gross margins exceed 60%, and ROE approaches 50%, underscoring exceptional profitability. However, the price‑to‑earnings multiple of about 64 is well above the industry average of 37, and the DCF‑derived fair value is substantially lower than the current market price, indicating that the stock may be overvalued. Volatility is elevated at over 70% on a 30‑day basis and beta exceeds one, implying heightened sensitivity to market swings.
The recent launch of the International VOICE 2026 Developer Conference signals ongoing product innovation and could spark incremental demand for Advantest’s test systems. Despite a modest dividend yield of 0.19% and a low payout ratio, cash generation remains strong, providing a cushion for future investments. Overall, the blend of strong growth fundamentals with an elevated valuation and technical softness suggests a cautious stance, with upside potential contingent on sustained demand and successful execution of its development roadmap.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and RSI in lower‑mid range
  • Elevated volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong revenue growth and high operating margins
  • Overvalued multiples relative to peers
  • Potential upside from upcoming developer conference

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained profitability and cash generation
  • Secular demand for semiconductor test equipment
  • Low dividend payout supporting reinvestment

Key Metrics & Analysis

Financial Health

Revenue Growth25.50%
Profit Margin27.93%
P/E Ratio64.5
ROE49.26%
ROA28.25%
Debt/Equity13.53
P/B Ratio24.6
Op. Cash Flow¥334.2B
Free Cash Flow¥251.2B
Industry P/E36.8

Technical Analysis

TrendBullish
RSI39.9
Support¥22,120.00
Resistance¥29,345.00
MA 20¥26,309.00
MA 50¥23,956.80
MA 200¥16,277.00
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value¥13,471.31
Target Price¥26,236.84
Upside/Downside14.70%
GradeOvervalued
TypeGrowth
Dividend Yield0.19%

Risk Assessment

Beta1.27
Volatility74.56%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.